ADIAL PHARMACEUTICALS, INC. (ADIL) Operating income 2017–2025
ADIAL PHARMACEUTICALS, INC. (ADIL) annual operating income history from SEC filings — each fiscal year as reported.
-$7.8MFY2025 · since FY2017: -$995,286 → -$7.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.8M | +5.9% |
| FY2024 | -$8.3M | -20.3% |
| FY2023 | -$6.9M | +36.6% |
| FY2022 | -$10.9M | +43.7% |
| FY2021 | -$19.3M | -76.5% |
| FY2020 | -$10.9M | -32.5% |
| FY2019 | -$8.2M | -18.0% |
| FY2018 | -$7.0M | -602.0% |
| FY2017 | -$995,286 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ADIL financial trends
ADIL RevenueADIL Net incomeADIL Net marginADIL Gross profitADIL Gross marginADIL Operating marginADIL Operating cash flowADIL Free cash flowADIL Capital expendituresADIL Return on equityADIL Stock buybacksADIL Dividends paidADIL Total assetsADIL Total liabilitiesADIL Shareholders’ equityADIL overview →